ADN-138

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameADN-138
Drug Alias NameADN-138
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetic cataractDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyorin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetic cataractDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A